Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
Jones MR, Peng PC, Coetzee SG, Tyrer J, Reyes ALP, Corona RI, Davis B, Chen S, Dezem F, Seo JH, Kar S, Dareng E; Ovarian Cancer Association Consortium; Berman BP, Freedman ML, Plummer JT, Lawrenson K, Pharoah P, Hazelett DJ, Gayther SA.
Jones MR, et al.
Am J Hum Genet. 2020 Oct 1;107(4):622-635. doi: 10.1016/j.ajhg.2020.08.021. Epub 2020 Sep 17.
Am J Hum Genet. 2020.
PMID: 32946763
Free PMC article.